6505--VA Phoenix Radiopharmaceuticals Base DO

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

262-NETWORK CONTRACT OFFICE 22 (36C262)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C26226Q0334

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Department of Veterans Affairs (VA), through its 262-Network Contract Office 22, has issued an award notice for the procurement of radiopharmaceuticals to support the VA Phoenix facility. This procurement, identified under solicitation number 36C26226Q0334, falls within the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing. The associated Product Service Code is 6505, further specifying the focus on pharmaceutical products. The primary objective of this contract is to ensure a reliable and consistent supply of radiopharmaceuticals for the VA Phoenix location. Radiopharmaceuticals are critical components in diagnostic imaging and therapeutic procedures, playing a vital role in the healthcare services provided to veterans. The scope of this procurement encompasses the manufacturing, preparation, and timely delivery of these specialized pharmaceutical products, adhering to stringent quality and safety standards required for medical use. The intended outcome of this contract is to enhance the VA Phoenix facility’s ability to deliver high-quality diagnostic and therapeutic care to its veteran patient population. By securing a dependable source of radiopharmaceuticals, the VA aims to minimize disruptions in patient care and support the ongoing operations of its medical imaging and treatment programs. Key requirements for this procurement include compliance with all applicable federal regulations governing pharmaceutical manufacturing, as well as adherence to VA-specific protocols for product quality, safety, and delivery logistics. Contractors are expected to demonstrate robust capabilities in the preparation and distribution of radiopharmaceuticals, ensuring that all deliverables meet the precise specifications outlined by the VA. The contracting activity is managed by the 262-Network Contract Office 22, a federal office within the Department of Veterans Affairs. The primary point of contact for this procurement is Hestia Sim, who can be reached via email at [email protected] for any inquiries related to the contract. This opportunity is classified as an award notice, indicating that the contract has already been awarded and is currently active as of the posting date, May 3, 2026. Interested parties can access further details and any available attachments through the official SAM.gov opportunity listing at https://sam.gov/opp/281a540948ef4acab0709bee18ff1d4e/view. Contractors evaluating similar opportunities should note the focus on pharmaceutical manufacturing for medical applications, the federal contracting environment, and the importance of compliance with both industry and VA-specific standards. The contract’s core requirements and objectives are expected to remain consistent throughout its lifecycle, centering on the provision of high-quality radiopharmaceuticals to support veteran healthcare services at the VA Phoenix facility.